Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Cardiex.
RELATED STOCKHEAD STORIES
News
Rise and Shine: Everything you need to know before the ASX opens
Health & Biotech
ASX Health Stocks: Cardiex jumps 15pc on sales update; Recce’s drug included in WHO’s report
Health & Biotech
Cardiex’s CONNEQT Pulse included on the US Blood Pressure Validated Device List
Health & Biotech
ASX Health Stocks: Recce, Cynata say their diabetic foot ulcer trials are going great guns
News
Top 10 at 11: Enova inks rare earth Brazil deal, Credit Clear upgrades FY24 guidance
Health & Biotech
Regal cornerstones $14m CardieX raise as medtech prepares to debut world-first vascular biometric monitor
News
Rise and Shine: Everything you need to know before the ASX opens
News
Closing Bell: Local markets fall on timid Tuesday but Biotron bets build as investors ask if it’s aced an anti-viral AIDS therapy
News
Rise and Shine: Everything you need to know before the ASX opens
News
Closing Bell: Range-bound benchmark ends washboard flat, cheapened us all during August
Health & Biotech
Curvebeam AI CEO says medical devices beat drugs to revenue, massive market in medical imaging
Health & Biotech
Strokes cost the Australian economy billions, but these biotech players could change that
Health & Biotech
ASX biotechs are looking up, and the FDA breakthroughs are starting to flow
Health & Biotech
MST upgrades CardieX to 5x current share price as FDA green lights world-first vascular biometric monitor
News
In Case You Missed It: Battery and base metals, oil and US FDA clearance for blood pressure tech
Health & Biotech
Blood Pressure Breakthrough: CardieX gets FDA green light for world-first vascular biometric monitor
Health & Biotech